Middle-aged and older people taking glucagon-like peptide 1 receptor agonists (ScimexNew diabetes and weight loss drugs could be reducing the risk of dementia and strokeNew diabetes and weight loss drugs could be reducing the risk of dementia and stroke
Middle-aged and older people taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs) such as Ozempic or Mounjaro for type 2 diabetes and obesity could be less likely to develop dementia or have a
#glp
1 post1 participant0 posts today
https://www.europesays.com/2181332/ Gegner fordert: Lest die EU-Verträge selbst! #bürger #EU #EuVerträge #Europa #Europe #fdp #GLP #JürgGrossen #lesen #MatthiasMüller #Politik #schweiz
EUROPE SAYS · Gegner fordert: Lest die EU-Verträge selbst! - EUROPE SAYSDie Katze ist aus dem Sack: Seit Freitag sind die EU-Verträge öffentlich. Sollte man das Mega-Dokument als Bürger selbst lesen? Die Meinungen gehen auseinander.
Wie kann mensch in der Schweiz eigentlich ohne Reue und schlechtes Gewissen den Ersten August feiern und in den Spiegel gucken, ohne ab sich selber erbrechen zu müssen, wenn mensch sich die nachfolgenden behindertenfeindlichen (Nicht-)Entscheide unserer gewählten Vertretenden ansieht?
[1/3]
uspol,healthcare
Weight-loss drugs can improve #kidney health, study find - https://www.theguardian.com/science/2024/nov/25/weight-loss-drugs-can-improve-kidney-health-study-finds "Analysis involving more than 85,000 people showed risk of worsening function was reduced by 22%" #GLP
The Guardian · Weight-loss drugs can improve kidney health, study finds
Continued thread
Sorry, #dulaglutide med #trulicity; the more general description of these drugs is #glp1 receptor agonists.
Apparently various professional orgs have been kinda all over the map on whether or not to hold such meds pre-op, but now they are coalescing -- still without formal evidence-based guidance, mind you -- around 24-hour liquid diet in preoperative phase, especially for higher doses of the meds for patients on weekly regimens.
Medscape · GLP-1 RAs Safe in the Perioperative Period: New Guidance
ICYMI: #Semaglutide & #Tirzeputide are miracle drugs.
#GLP-1s like #Ozempic are among the most important drug breakthroughs ever - Economist
https://www.economist.com/briefing/2024/10/24/glp-1s-like-ozempic-are-among-the-most-important-drug-breakthroughs-ever
The Top 10 Long-Term Health Benefits of Activating GLP-1 - LifeAdvantage
https://www.lifevantage.com/us-en/blog/the-top-10-long-term-health-benefits-of-activating-glp-1
5 Ways Ozempic, #Wegovy, and Other Weight Loss Drugs May Improve Your Health - Healthline
https://www.healthline.com/health-news/ways-ozempic-wegovy-improve-health
The Economist · GLP-1s like Ozempic are among the most important drug breakthroughs ever
From 29 Aug: Eli Lilly raises price of Zepbound while trumpeting discount on starter vials - Enlarge / An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough o... https://arstechnica.com/science/2024/08/eli-lilly-raises-price-of-zepbound-while-trumpeting-discount-on-starter-vials/ #bernie-sanders #drug-prices #eli-lilly #glp-1 #health-insurance #lilly #prescription-drugs #sanders #science #weight-loss-drugs #zepbound
Eli Lilly raises price of Zepbound while trumpeting discount on starter vials - Enlarge / An Eli Lilly & Co. Zepbound injection pen arranged in the... - https://arstechnica.com/?p=2046139 #prescriptiondrugs #healthinsurance #weightlossdrugs #berniesanders #drugprices #elililly #zepbound #science #sanders #glp-1 #lilly
Ars Technica · Eli Lilly raises price of Zepbound while trumpeting discount on starter vialsCost for insured patients without coverage for the drug rises from $550 to $650 a month.
The dangers of losing weight faster than your doctors can keep up - Enlarge (credit: Getty | Spauln)
The dose makes the medicine—a... - https://arstechnica.com/?p=2041166 #hypothyroidism #trizepatide #science #obesity #thyroid #health #dosage #glp-1
Ars Technica · Man suffers heart problem after rapid weight loss: A GLP-1 cautionary taleThe man developed atrial fibrillation and required hospitalization.
People are overdosing on off-brand weight-loss drugs, FDA warns - Enlarge / Wegovy is an injectable prescription weight-loss medicine tha... - https://arstechnica.com/?p=2039643 #semaglutide #weightloss #diabetes #science #health #glp-1 #fda
Ars Technica · People are overdosing on off-brand weight-loss drugs, FDA warnsBad math and unclear directions are behind overdoses of up to 20 times the normal amount.
A group of residents in Tokyo is aiming to block construction of a massive logistics and data center planned by Singaporean developer GLP. https://www.japantimes.co.jp/business/2024/07/10/tokyo-data-center/ #business #akishima #glp #datacenters
The Japan Times · Tokyo residents seek to block building of massive data center
From 09 Jul: New weight-loss and diabetes drugs linked to lower risk of 10 cancers - Enlarge / Ozempic is a GLP-1 drug for adults with type 2 diabetes.Getty Steve Christo ... https://arstechnica.com/science/2024/07/new-weight-loss-and-diabetes-drugs-linked-to-lower-risk-of-10-cancers/ #cancer #glp-1 #obesity-related-cancer #ozempic #science #type-2-diabetes #wegovy #weight-loss #weight-loss-drugs
Surprise! I got to co-host this week's Readout Loud #podcast (perhaps the first all-women ROL ep ever?? write in if you know)
We discussed #Medicare coverage for #GLP-1 drugs with our Washington colleague Rachel Cohrs Zhang, what she's watching at tonight's presidential #debate, #AI in #biotech, and more!
@STAT
https://www.statnews.com/2024/06/27/readout-loud-podcast-medicare-weight-loss-drugs-health-care-presidential-debate/
STAT · Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debateThis week on "The Readout LOUD" podcast: Will Medicare finally begin covering the new weight loss drugs? And what health care issues may be lightening rods in this election?
For a company that was founded to "defeat Mother Nature," #Google's #healthtech company #Verily's latest pivot is strangely pedestrian.
It's turning its chronic care program Onduo into a new platform called Lightpath that prescribes #GLP-1s & collects wearable data (including from OTC CGMs for non-diabetic patients) with #AI
for @STAT: https://www.statnews.com/2024/06/11/google-verily-glp1-weight-loss-drugs-lightpath-onduo/
STAT · Google’s Verily to offer GLP-1 drugs through Lightpath, its retooled chronic care appGoogle's Verily is pivoting, again. Its chronic disease management app Onduo will transition to a new, “evolved” product called Lightpath.
The next food marketing blitz is aimed at people on new weight-loss drugs - Enlarge (credit: Getty | Jeffrey Greenberg)
As new diabetes an... - https://arstechnica.com/?p=2026494 #weightwatchers #dailyharvest #foodindustry #weightloss #mounjaro #zepbound #science #ozempic #nestle #wegovy #glp-1 #diet #food #gnc
Ars Technica · The next food marketing blitz is aimed at people on new weight-loss drugsTaking a weight-loss drug? Food makers have just the new food for you.
“Outrageously” priced weight-loss drugs could bankrupt US health care - Enlarge / Packaging for Wegovy, manufactured by Novo Nordisk, is seen i... - https://arstechnica.com/?p=2025320 #healthcarecosts #berniesanders #weightloss #medicaid #medicare #premiums #science #health #wegovy #glp-1
Ars Technica · “Outrageously” priced weight-loss drugs could bankrupt US health carePrices would need to be dramatically slashed to avoid increasing the national deficit.
#Wegovy®, #Zepbound®, and similar medications continue to gain attention for effectively treating #obesity, and now there is discussion—with research underway—about their potential for improving certain #surgical outcomes.
The brand-name medications mentioned above belong to a class called GLP-1 (glucagon-like peptide-1) agonists. #GLP-1s mimic the actions of the GLP-1 hormone, which is secreted in the gut and sends an “I’m full” signal to the brain after you eat.
GLP-1 medications aren’t new. @Ozempic® (generic name: #semaglutide) received approval from the U.S. Food and Drug Administration (FDA) to treat type 2 diabetes in 2017.
After its weight-loss effects were studied, semaglutide (at a higher dose and sold under the name Wegovy) was approved by the FDA as an anti-obesity medication in 2021, and others have since followed.
Most recently, the FDA approved Wegovy for patients with #cardiovascular #disease and obesity or overweight after a study showed that those taking the medication had a lower overall risk of major cardiac events, such as heart attack, stroke, or cardiovascular-related death.
Now, some Yale Medicine surgeons believe, based on their ongoing research, that taking anti-obesity medications before and sometimes after total #joint #replacement and #bariatric #surgery can be beneficial.
“These medications have been transformative, in terms of expanding the pool of people who can safely undergo joint replacement surgery,” says Daniel Wiznia, MD, a Yale Medicine orthopaedic surgeon and co-director of the Avascular Necrosis Program.
“These anti-obesity medications are game-changers; they are changing the way people practice medicine.”
Often, patients who need a total hip or knee replacement must delay surgery until they lose enough weight to meet specific body mass index ( #BMI ) standards.
This is important in protecting the patient’s health.
“Weight increases a patient’s risk of postoperative complications, including wound-healing problems, stroke, heart attack, blood clots, and infection,” he says.
However, having patients take a GLP-1 medication before surgery, as well as improving their diet, has allowed more patients to reach a safe preoperative BMI, Dr. Wiznia says.
https://www.yalemedicine.org/news/anti-obesity-medications-before-surgery